Details for Patent: 8,541,393
✉ Email this page to a colleague
Which drugs does patent 8,541,393 protect, and when does it expire?
Patent 8,541,393 protects DEFENCATH and is included in one NDA.
This patent has thirteen patent family members in eight countries.
Summary for Patent: 8,541,393
| Title: | Antimicrobial locking solutions comprising taurinamide derivatives and biologically acceptable salts and acids, with the addition of small concentrations of heparin |
| Abstract: | The present invention relates to inhibiting or preventing infection and protecting against patency complications after a blood catheter has been inserted in a patient comprising administering to the device a pharmaceutically effective amount of a composition comprising (A) at least one taurinamide derivative, (B) at least one compound selected from the group consisting of biologically acceptable acids and biologically acceptable salts thereof; and (C) heparin at a low concentration. |
| Inventor(s): | Prosl Frank R. |
| Assignee: | ND Partners, LLC |
| Application Number: | US13199605 |
|
Patent Claim Types: see list of patent claims |
Drugs Protected by US Patent 8,541,393
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cormedix | DEFENCATH | heparin sodium; taurolidine | SOLUTION;N/A | 214520-001 | Nov 15, 2023 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | Y | A CATHETER LOCK SOLUTION TO REDUCE CATHETER-RELATED BLOODSTREAM INFECTIONS IN ADULT PATIENTS RECEIVING HEMODIALYSIS THROUGH A CENTRAL VENOUS CATHETER | ⤷ Try a Trial | ||
| Cormedix | DEFENCATH | heparin sodium; taurolidine | SOLUTION;N/A | 214520-002 | Nov 15, 2023 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | Y | A CATHETER LOCK SOLUTION TO REDUCE CATHETER-RELATED BLOODSTREAM INFECTIONS IN ADULT PATIENTS RECEIVING HEMODIALYSIS THROUGH A CENTRAL VENOUS CATHETER | ⤷ Try a Trial | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,541,393
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| China | 101094679 | ⤷ Try a Trial | |||
| China | 103083353 | ⤷ Try a Trial | |||
| Germany | 202005022124 | ⤷ Try a Trial | |||
| Denmark | 1814562 | ⤷ Try a Trial | |||
| European Patent Office | 1814562 | ⤷ Try a Trial | |||
| European Patent Office | 2742945 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
